Eric Obscherning is a consultant at C&M International where he supports the firm’s global health practice, advising Fortune 100 biopharmaceutical and medical device companies and their trade associations as they enter emerging markets, navigate policies and regulations, and develop strategic initiatives and public-private partnerships. He works at the intersection of business strategy, public policy, and government affairs on issues related to life sciences innovation, rare diseases, vaccines confidence, healthcare financing, HPV and cervical cancer, tuberculosis, antimicrobial resistance, and regulatory harmonization.
Prior to joining C&M International, Eric was a consultant with Manchester Trade, involved in corporate social responsibility at GlobalGiving, and an early employee of an aquaponics startup. His written work has appeared in Governance in an Emerging New World (Hoover Institution Press), Climate Change & Public Health (Oxford University Press), Journal of the American Medical Association, and Global Heart. He received a BS in biology and English and a Certificate in Global Health from the University of Wisconsin-Madison, and studied NCDs and precision medicine at the U.S. National Institutes of Health.